A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors

NCT04761198 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult
Advanced Solid Tumor
Metastatic Solid Tumor

Interventions

DRUG: Etigilimab
DRUG: Nivolumab

Sponsor

Mereo BioPharma

Collaborators

[object Object]